Evidence map›Paper›PMID 35740585›Full record

ReviewCancers2022

Toward a Mechanistic Understanding of Poly- and Perfluoroalkylated Substances and Cancer.

Raya I Boyd, Saeed Ahmad, Ratnakar Singh, Zeeshan Fazal, Gail S Prins, Zeynep Madak Erdogan, Joseph Irudayaraj, Michael J Spinella

Open access · goldAbstract readReview
In one paragraph

Review in Cancers, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 48 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed, 1 pooled it
10.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

48 citing papers in PubMed, 1 synthesis or guideline pooled it, 94 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Review
  13. Review
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Raya I BoydDepartment of Comparative Biosciences, University of Illinois, Urbana-Champaign, Urbana, IL 61802, USA.ORCID 0000-0002-7494-1220
Saeed AhmadDepartment of Bioengineering, University of Illinois, Urbana-Champaign, Urbana, IL 61801, USA.
Ratnakar SinghDepartment of Comparative Biosciences, University of Illinois, Urbana-Champaign, Urbana, IL 61802, USA.ORCID 0000-0002-3226-3847
Zeeshan FazalDepartment of Comparative Biosciences, University of Illinois, Urbana-Champaign, Urbana, IL 61802, USA.ORCID 0000-0003-0111-7668
Gail S PrinsDepartments of Urology, Pathology and Physiology, College of Medicine, Chicago Center for Health and Environment, University of Illinois Chicago, Chicago, IL 60612, USA.
Zeynep Madak ErdoganDepartment of Food Science and Human Nutrition, Division of Nutritional Sciences, University of Illinois Urbana-Champaign, Urbana, IL 61801, USA.ORCID 0000-0003-2607-1643
Joseph IrudayarajDepartment of Bioengineering, University of Illinois, Urbana-Champaign, Urbana, IL 61801, USA.ORCID 0000-0002-0630-1520
Michael J SpinellaDepartment of Comparative Biosciences, University of Illinois, Urbana-Champaign, Urbana, IL 61802, USA.
University of Illinois Urbana-Champaign · USUniversity of Illinois Chicago · US

Funding

Pilot Program CoreP30ES027792 · NIEHS · UNIVERSITY OF CHICAGO · PI Gokhan M. Mutlu, Gail S Prins · 2017 to 2026
$13.6M
Research Training Program in Toxicology and Environmental HealthT32ES007326 · NIEHS · UNIVERSITY OF ILLINOIS URBANA-CHAMPAIGN · PI Jodi A. Flaws · 2000 to 2026
$8.7M
DNA Methylation Inhibitor Therapy for Testicular CancerR01CA211875 · NCI · UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN · PI SPINELLA, MICHAEL J · 2018 to 2022
$2.5M
NCI NIH HHS R01 CA211875NCI NIH HHS R01CA211875NIEHS NIH HHS P30 ES027792NIEHS NIH HHS T32 ES007326
6 · The paper itself

Abstract

Poly- and perfluoroalkylated substances (PFAS) are chemicals that persist and bioaccumulate in the environment and are found in nearly all human populations through several routes of exposure. Human occupational and community exposure to PFAS has been associated with several cancers, including cancers of the kidney, testis, prostate, and liver. While evidence suggests that PFAS are not directly mutagenic, many diverse mechanisms of carcinogenicity have been proposed. In this mini-review, we organize these mechanisms into three major proposed pathways of PFAS action-metabolism, endocrine disruption, and epigenetic perturbation-and discuss how these distinct but interdependent pathways may explain many of the proposed pro-carcinogenic effects of the PFAS class of environmental contaminants. Notably, each of the pathways is predicted to be highly sensitive to the dose and window of exposure which may, in part, explain the variable epidemiologic and experimental evidence linking PFAS and cancer. We highlight testicular and prostate cancer as models to validate this concept.

Indexed as

epigeneticsmetabolomicPFOAPFOSprostate cancertesticular cancer

Identifiers

PMID35740585
PMCPMC9220899
OpenAlexW4282832526

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.